Latest Breaking News On - Heather savelle - Page 9 : comparemela.com

TScan Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update

TScan Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDavidp southwellDebora bartonHeather savelleJoyce allaireHematologic malignancies programCompany phaseNovartis institutes for biomedical researchLifesci advisorsSociety for immunotherapy of cancerDrug administrationErnestn morial convention centerAmerican society of hematologyTscan therapeutics incInds for the companyGlobe newswire tscan therapeutics inc

TScan Therapeutics Announces Upcoming Poster Presentation

WALTHAM, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the.

United statesHeather savelleJoyce allaireLifesci advisorsColumbia university medical centerErnestn morial convention centerTscan hematologic malignancies programAmerican society of hematologyTscan therapeutics incSecurities exchangeAmerican societyAnnual meetingEran reshefColumbia university medicalEarly phaseInvestigational therapies

TScan Therapeutics to Participate in Upcoming Investor Conferences

TScan Therapeutics to Participate in Upcoming Investor Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesHeather savelleJoyce allaireTscan therapeutics incLifesci advisorsGlobe newswire tscan therapeutics incGenetic medicine summitLotte new york palaceAnnual genetic medicines conferenceWestin grand centralSci advisors

TScan Therapeutics Secures Convertible Debt Facility for up to $60 Million with K2 HealthVentures

TScan Therapeutics Secures Convertible Debt Facility for up to $60 Million with K2 HealthVentures
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Davidp southwellParag shahHeather savelleJoyce allaireInds for the companyTscan therapeutics incLifesci advisorsExchange commission onGlobe newswire tscan therapeutics incSecurities exchangeWall streetChief executivePrime rateExchange commissionFounding managing directorPrivate securities litigation reform act

TScan Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress

10.08.2022 - Phase 1 umbrella trial for hematologic malignancies open for enrollment Publication in Cell further validates use of foundational technology to identify novel tumor antigens and effective TCRs TSC-200-A2 (HPV) and TSC-204-C7 (MAGE-A1) IND filings .

Sao pauloUnited statesDavidp southwellKai wucherpfennigDebora bartonHeather savelleJoyce allairePontificia universidade catolicaBroad instituteCelgene corporationTscan therapeutics incGlobe newswire tscan therapeutics incAmerican society of geneIovance biotherapeutics incCarisma therapeutics incDana farber cancer institute